Strides Pharma gains as its arm gets USFDA's nod for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets

15 Jan 2021 Evaluate

Strides Pharma Science is currently trading at Rs. 923.25, up by 1.90 points or 0.21% from its previous closing of Rs. 921.35 on the BSE.

The scrip opened at Rs. 933.00 and has touched a high and low of Rs. 938.75 and Rs. 923.05 respectively. So far 6339 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1000.00 on 08-Jan-2021 and a 52 week low of Rs. 271.00 on 20-Mar-2020.

Last one week high and low of the scrip stood at Rs. 963.30 and Rs. 892.05 respectively. The current market cap of the company is Rs. 8293.07 crore.

The promoters holding in the company stood at 29.69%, while Institutions and Non-Institutions held 42.24% and 28.07% respectively.

Strides Pharma Science’s (Strides’) step-down wholly owned subsidiary -- Strides Pharma Global, Singapore, has received approval for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, 200 mg/300 mg from the United States Food & Drug Administration (USFDA). The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Truvada Tablets, 200 mg/300 mg, of Gilead Sciences.

The company has 127 cumulative ANDA filings with USFDA of which 95 ANDAs have been approved and 32 are pending approval.

Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.

Strides Pharma Scien Share Price

845.95 8.55 (1.02%)
18-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1523.80
Dr. Reddys Lab 5959.10
Cipla 1352.95
Zydus Lifesciences 934.50
Lupin 1599.65
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.